Cardiology

A recent study has found that consumption of coffee may not be as bad as previous studies have portrayed.

BioMarin announced the investigative gene therapy reached pre-specified criteria for Factor VIII levels in adult patients with severe hemophilia A.

The signs and symptoms of the rare, chronic condition are not consistently detected in the first line of care.

Sleep apnea is associated with pulmonary, cardiovascular, psychiatric, neurologic, and weight-related effects. Primary care physicians need to monitor sleep health more.

Previous analyses into MultiStem Cell Therapy have shown benefits and safety in stroke patients. What will it take for the therapy to reach a phase 3 trial for ARDS?

Though the prostacyclin-targeting therapy selexipag is beneficial for PAH patients, investigators advise treatment to a trio of pathways.

Why are major adverse cardiovascular events not treated as the concern risk factors they are in patients with obstructive sleep apnea?

Upper airway stimulation, a sleep apnea treatment on the rise, is showing particular benefit for female patients.

Recent study found that having post-traumatic stress disorder, in and of itself, does not increase a patient's risk for cardiovascular disease. 

A 42-year-old female with no significant past medical history presents to the emergency department for two days of constant non-pleuritic, non-exertional, non-radiating chest pain associated with feeling light-headed. What is the diagnosis?

How new GRIPHON data showed further definitive long-term outcomes for patients with pulmonary hypertension.

Positive findings for the envelope support some of the first indications that a preventive measure could address cardiac surgery infection rates.

Teens and adults had similar weight loss after gastric bypass surgery, but teens were more likely to experience remission of type 2 diabetes and hypertension than adults.

Dalteparin sodium injection was shown to result in VTE resolution in a majority of treated patients from a clinical trial.

Thyroid hormones have a wide range of effects of the cardiovascular system. Too much or too little thyroiid hormones can induce or exacerbate existing cardiovascular disorders. In this article, we highlight the treatment recommendations for thyroid-related CVD events.

Machine Learning algorithm analyzes 85 individual variables to determine a person's risk of having a heart attack or death with more than 90% accuracy.

The KardiaMobile 6L device is the first FDA-cleared 6-lead electrocardiogram (ECG) device for personal use.

A recent study found that 33.7% of patients on statins fail to lower their LDL-C to the recommended threshold of 100 mg per dL.

Patients who experienced hypertensive disorders in pregnancy were 80% more likely to develop choroidal neovascular AMD at an early age.

Findings from ASCENT-COPD show the long-acting muscarinic antagonist is noninferior to placebo in driving major adverse cardiovascular event risk in very at-risk patients with COPD.

New data from PARTNER 3 shows the procedure reduces one-year mortality in patients with aortic stenosis.

Tafamidis and tafamidis meglumine reported a greater survival rate in treated patients than those administered placebo, and reported a reduced rate of hospitalizations from cardiovascular problems.

Results of this study, which examines lifelong endogenous testosterone exposure, add to the body of evidence in support of regulatory warnings about testosterone replacement therapy.  

The SmartSync includes a mobile application, telemetry head, and pacing system analyzer that allows for direct patient-to-physician data sharing.